Quinoline

Quinoline

SCHEMBL29349552

c1ccc2ncccc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
NPC1 O15118 2/20 0.58
POLB P06746 1/20 0.58
RAB9A P51151 1/20 0.58
CYP3A4 P08684 3/20 0.56
MAPT P10636 5/20 0.54
HTT P42858 3/20 0.54
KDM4E B2RXH2 3/20 0.54
CASP1 P29466 2/20 0.54
TP53 P04637 2/20 0.54
HSP90AA1 P07900 2/20 0.54
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
MEN1 O00255 1/20 0.54
CASP7 P55210 1/20 0.54
KMT2A Q03164 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54
NR4A2 P43354 1/20 0.54
HSP90AB1 P08238 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL32661377 1.00 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL1270969 1.00 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL2774 1.00 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL29822171 1.00 ALDH1A1 (1.00) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL23202414 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL5422407 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL4955314 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL18062510 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL20969722 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4
Quinoline SCHEMBL1935828 0.97 ALDH1A1 (0.94) ALDH1A1NPC1POLBRAB9ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4332140-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED PRODUCT, AND METHOD OF PRODUCING OPTICAL MATERIAL MITSUI CHEMICALS INC (JP) 2026-05-27 EP claimed
EP-4263544-B1 INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS UDC IRELAND LTD (IE) 2026-05-13 EP claimed
EP-4037900-B1 LED ILLUMINATION ELEMENTS BASED ON MULTILAYER BODIES WITH SOLID STONE APPEARANCE COVESTRO DEUTSCHLAND AG (DE) 2026-05-06 EP claimed
EP-3985750-B1 LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2026-04-29 EP claimed
EP-4731688-A1 METHOD FOR THE PRODUCTION OF A HYDROXYL-GROUP TERMINATED OXAZOLIDINONE COMPOSITION Covestro Deutschland AG (DE) 2026-04-29 EP claimed
EP-4731209-A1 PROCESSES FOR PREPARING SOLUBLE GUANYLATE CYCLASE STIMULATORS Merck Sharp & Dohme LLC (US) 2026-04-29 EP claimed
EP-3762382-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2026-04-29 EP claimed
EP-4251383-B1 METHOD FOR TREATING WOOD HOUTINDUSTRIE MEVO B V (NL) 2026-04-08 EP claimed
EP-4720073-A1 SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS Kura Oncology, Inc. (US) 2026-04-08 EP claimed
EP-4116393-B1 ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2026-04-01 EP claimed
EP-3464400-B1 POLYMER LINKERS AND THEIR USES NOVACYTE THERAPEUTICS COMPANY LTD (CN) 2022-04-06 EP claimed
EP-3749668-B1 CONTINUOUS PROCESS FOR THE PREPARATION OF TRAZODONE ACRAF (IT) 2022-04-06 EP claimed
EP-3974416-A1 NOVEL ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2022-03-30 EP claimed
EP-3362453-B1 CYCLIC ETHER DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYAMIDE BOEHRINGER INGELHEIM INT (DE) 2022-03-30 EP claimed
WO-2022060466-A1 COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-03-24 WO claimed
US-20220087950-A1 COMPOUNDS, TARGETS AND PATHWAYS FOR MACROPHAGE MODULATION NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-03-24 US claimed
EP-3565816-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-03-16 EP claimed
EP-3355888-B1 HEMI-SYNTHETIC TRILOBINE ANALOGS FOR USE AS A DRUG PF MEDICAMENT (FR) 2022-03-09 EP claimed
EP-3402588-B1 PROCESS FOR IMPROVED WATER FLUX THROUGH A TFC MEMBRANE LG NANOH2O INC (US) 2022-03-02 EP claimed
EP-3533794-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-02-23 EP claimed